Biosyent Inc ($RX) - buy or sell? Stock discussion, ideas, forum

Biosyent Inc

BioSyent, Inc.

Industry: Consumer, Non-cyclical

Ticker	Exchange	ISIN
$RX	TSXV	CA0906901081

Recent news

Kinaxis Inc Net Income dropped on 41.2% while Revenue surged on 17.0%

B2Gold Corp reports 114% Net Income growth in 2020 and 11.0 pp EBITDA Margin growth from 65.6% to 76.6%

Tucows Inc reports 35.8% EBITDA decline in 2020 and 7.7% Revenue decline

KFG Resources Ltd reports 23.7% revenue decline in FY2020 and 25.1 pp EBITDA Margin decline from -3.5% to -28.6%

EXFO Inc EBITDA dropped on 30.3% and Revenue decreased on 7.4%

Arctic Hunter Energy Inc revenue decline accelerated to 47.8% in FY2020 vs. 37.7% a year earliner

Canyon Creek Food Co Ltd reports 38.5% revenue growth in FY2020 and 0.53 pp EBITDA Margin decline from -13.1% to -13.7%

Orbit Garant Drilling Inc Debt surged on 39.8% and Net Debt / EBITDA surged on 1.1x from 3.0x to 4.1x

Rochester Resources Ltd revenue returned to growth in FY2020: increased 13.2% vs. 19.2% decline a year earliner

Quizam Media Corp reports 8.0% revenue decline in FY2020 and 80.7 pp EBITDA Margin growth from -265% to -184%

Twit about RX stock

Share your investment idea or question on Biosyent Inc stock:

Latest twits on Biosyent Inc (RX)

No twits yet. Be the first to post!

Have a question about RX? Ask and other investors will be eager to help you.

Have an idea about RX? Share it with other investors.

Biosyent Inc news

15.03.2017 Biosyent Inc EBITDA Margin dropped on 33.3 pp from 33.3% to in 2016

11.03.2016 Looking for a growth stock? Pay attention to Biosyent Inc

04.03.2016 Biosyent Inc revenue surged on 26.0% in 2015 while EBITDA Margin decreased slightly on 1.9 pp from 35.2% to 33.3%

04.03.2015 Eye on Biosyent Inc with its long history of healthy growth

Biosyent Inc stock price chart

Biosyent Inc financials

mln. CAD	FY2010	FY2011	FY2012

Revenue	1.681	2.809	5.024
EBITDA	0.063	0.427	1.410
Net income	0.048	0.420	1.541
CAPEX	0.000	0.017	0.089
Debt	0.000	0.000	0.000
Cash	0.471	1.058	2.316

Biosyent Inc news

About Biosyent Inc

BioSyent, Inc. operates as a specialty pharmaceutical company. The Company acquires or licenses the rights to pharmaceuticals and manages them through the regulatory process. BioSyent markets these products in Canada.